PC
PFE icon

Palo Capital’s Pfizer PFE Stock Holding History

Palo Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$2.19M Buy
52,929
+1,191
+2% +$49.4K 0.93% 45
2018
Q3 		$2.16M Sell
51,738
-648
-1% -$24.9K 0.78% 50
2018
Q2 		$1.8M Buy
52,386
+541
+1% +$18.5K 0.66% 57
2018
Q1 		$1.75M Buy
51,845
+17,970
+53% +$618K 0.63% 64
2017
Q4 		$1.16M Buy
33,875
+316
+0.9% +$10.8K 0.52% 61
2017
Q3 		$1.14M Buy
33,559
+487
+1% +$15.7K 0.6% 62
2017
Q2 		$1.05M Buy
33,072
+35
+0.1% +$1.1K 0.6% 66
2017
Q1 		$1.07M Buy
33,037
+12,666
+62% +$399K 0.63% 62
2016
Q4 		$628K Buy
20,371
+3,779
+23% +$115K 0.4% 85
2016
Q3 		$533K Sell
16,592
-7,701
-32% -$258K 0.37% 83
2016
Q2 		$812K Buy
24,293
+13,816
+132% +$441K 0.28% 92
2016
Q1 		$295K Sell
10,477
-2,693
-20% -$76.9K 0.23% 103
2015
Q4 		$403K Buy
13,170
+1,355
+11% +$42.6K 0.37% 95
2015
Q3 		$352K Buy
11,815
+1,897
+19% +$60.8K 0.31% 103
2015
Q2 		$316K Buy
9,918
+759
+8% +$24.7K 0.25% 105
2015
Q1 		$302K Sell
9,159
-20,090
-69% -$639K 0.25% 100
2014
Q4 		$864K Buy
+29,249
New +$839K 0.73% 65

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Palo Capital's PFE Position: Q4 2018 in Review

Palo Capital increased its Pfizer (PFE) stake by 2.3% in Q4 2018, buying an estimated $49.4K and bringing the position to 52,929 shares worth $2.19M. The position accounts for 0.93% of the portfolio, ranked #45.

Palo Capital first reported a position in PFE in Q4 2014 and has held it in 17 quarters since. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Palo Capital held 52,929 shares of Pfizer worth $2.19M as of Q4 2018.
  • Palo Capital bought 1,191 Pfizer shares in Q4 2018, an estimated $49.4K.
  • Pfizer made up 0.93% of Palo Capital's portfolio in Q4 2018, its #45 holding.
  • Palo Capital first reported a position in Pfizer in Q4 2014 and has held it in 17 quarters since.
  • 2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Palo Capital's 13F filing for Q4 2018, filed 30 Jan 2019.